NASDAQ:FTRE Fortrea (FTRE) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free FTRE Stock Alerts $25.39 +1.17 (+4.83%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$24.83▼$25.5450-Day Range$24.22▼$40.2852-Week Range$24.18▼$41.02Volume2.23 million shsAverage Volume1.76 million shsMarket Capitalization$2.27 billionP/E RatioN/ADividend YieldN/APrice Target$32.78 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Fortrea alerts: Email Address Fortrea MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.55 Rating ScoreUpside/Downside29.1% Upside$32.78 Price TargetShort InterestHealthy6.36% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.72Based on 22 Articles This WeekInsider TradingAcquiring Shares$248,100 Bought Last QuarterProj. Earnings Growth121.25%From $0.80 to $1.77 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.83 out of 5 starsMedical Sector224th out of 924 stocksMedical Laboratories Industry8th out of 19 stocks 4.3 Analyst's Opinion Consensus RatingFortrea has received a consensus rating of Moderate Buy. The company's average rating score is 2.55, and is based on 5 buy ratings, 4 hold ratings, and 1 sell rating.Amount of Analyst CoverageFortrea has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Fortrea's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted6.36% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 5.1.Change versus previous monthShort interest in Fortrea has recently decreased by 14.22%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldFortrea does not currently pay a dividend.Dividend GrowthFortrea does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for FTRE. Previous Next 3.2 News and Social Media Coverage News SentimentFortrea has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 22 news articles for Fortrea this week, compared to 3 articles on an average week.Search Interest3 people have searched for FTRE on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat Follows6 people have added Fortrea to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Fortrea insiders have bought more of their company's stock than they have sold. Specifically, they have bought $248,100.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 0.12% of the stock of Fortrea is held by insiders.Read more about Fortrea's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Fortrea are expected to grow by 121.25% in the coming year, from $0.80 to $1.77 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fortrea is -18.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fortrea is -18.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioFortrea has a PEG Ratio of 2.07. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioFortrea has a P/B Ratio of 1.43. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Fortrea's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. About Fortrea Stock (NASDAQ:FTRE)Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.Read More FTRE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FTRE Stock News HeadlinesMay 31 at 9:02 AM | insidertrades.comFortrea Holdings Inc. (NASDAQ:FTRE) CEO Thomas Pike Buys 10,000 SharesJune 2 at 4:50 AM | americanbankingnews.comFortrea Holdings Inc. (NASDAQ:FTRE) Sees Large Drop in Short InterestJune 1 at 5:33 AM | americanbankingnews.comThomas Pike Purchases 10,000 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) StockJune 1 at 1:54 AM | americanbankingnews.comAnalyzing Fortrea (FTRE) & Its PeersJune 1 at 1:22 AM | americanbankingnews.comFortrea (NASDAQ:FTRE) Shares Gap Up on Insider Buying ActivityMay 31 at 5:56 AM | americanbankingnews.comFortrea (NASDAQ:FTRE) Reaches New 52-Week Low at $24.69May 31 at 1:14 AM | americanbankingnews.comFortrea (FTRE) versus Its Rivals Head to Head ComparisonMay 30 at 7:00 AM | globenewswire.comFortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical ResearchMay 29, 2024 | msn.comMizuho Initiates Coverage of Fortrea Holdings (FTRE) with Neutral RecommendationMay 29, 2024 | americanbankingnews.comTD Cowen Begins Coverage on Fortrea (NASDAQ:FTRE)May 28, 2024 | markets.businessinsider.comMaintaining Hold on Fortrea Holdings Amidst Long-Term Recovery and Current Industry ChallengesMay 28, 2024 | americanbankingnews.comFortrea (NASDAQ:FTRE) Now Covered by MizuhoMay 28, 2024 | americanbankingnews.comCritical Analysis: Fortrea (FTRE) and The CompetitionMay 24, 2024 | americanbankingnews.comFortrea (NASDAQ:FTRE) Price Target Cut to $28.00May 16, 2024 | bizjournals.comDurham spinout from Labcorp cuts revenue projectionsMay 16, 2024 | globenewswire.comFortrea Appoints Machelle Sanders to Board of DirectorsMay 14, 2024 | msn.comBaird Upgrades Fortrea Holdings (FTRE)May 14, 2024 | msn.comThese Analysts Slash Their Forecasts On Fortrea Holdings After Q1 ResultsMay 14, 2024 | markets.businessinsider.comDemystifying Fortrea Holdings: Insights From 4 Analyst ReviewsMay 14, 2024 | finance.yahoo.comFortrea Holdings First Quarter 2024 Earnings: Misses ExpectationsMay 14, 2024 | finance.yahoo.comAn Intrinsic Calculation For Fortrea Holdings Inc. (NASDAQ:FTRE) Suggests It's 48% UndervaluedMay 14, 2024 | finance.yahoo.comFortrea Holdings Inc (FTRE) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...May 13, 2024 | investorplace.comFTRE Stock Earnings: Fortrea Holdings Misses EPS, Misses Revenue for Q1 2024May 13, 2024 | msn.comFortrea Holdings Non-GAAP EPS of -$0.04 misses by $0.04, revenue of $662.1M misses by $92.48MMay 13, 2024 | seekingalpha.comFortrea Holdings Inc. 2024 Q1 - Results - Earnings Call PresentationSee More Headlines Receive FTRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today6/02/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:FTRE CUSIPN/A CIK1965040 Webwww.fortrea.com Phone877-495-0816FaxN/AEmployees18,000Year FoundedN/APrice Target and Rating Average Stock Price Target$32.78 High Stock Price Target$44.00 Low Stock Price Target$27.00 Potential Upside/Downside+29.1%Consensus RatingModerate Buy Rating Score (0-4)2.55 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($1.39) Trailing P/E RatioN/A Forward P/E Ratio31.74 P/E Growth2.07Net Income$-3,400,000.00 Net Margins-4.11% Pretax Margin-2.80% Return on Equity4.76% Return on Assets1.87% Debt Debt-to-Equity Ratio0.98 Current Ratio1.47 Quick Ratio1.62 Sales & Book Value Annual Sales$3.11 billion Price / Sales0.73 Cash Flow$2.49 per share Price / Cash Flow10.21 Book Value$17.81 per share Price / Book1.43Miscellaneous Outstanding Shares89,400,000Free Float89,293,000Market Cap$2.27 billion OptionableOptionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Thomas H. Pike (Age 65)CEO, President & Chairman Comp: $2.19MMs. Jill McConnell (Age 49)Chief Financial Officer Comp: $735.39kMr. Mark A. Morais (Age 47)COO & President of Clinical Services Comp: $732.47kAmanda M. WarrenChief Accounting OfficerMs. Hima B. InguvaHead of Investor Relations & Corporate DevelopmentStillman HansonGeneral Counsel & Corporate SecretaryDr. John J. DoylePresident of ConsultingMore ExecutivesKey CompetitorsExact SciencesNASDAQ:EXASRadNetNASDAQ:RDNTGuardant HealthNASDAQ:GHVeracyteNASDAQ:VCYTViridian TherapeuticsNASDAQ:VRDNView All CompetitorsInsiders & InstitutionsThomas PikeBought 10,000 shares on 5/29/2024Total: $248,100.00 ($24.81/share)Boston PartnersBought 121,126 shares on 5/28/2024Ownership: 4.406%Cetera Advisors LLCBought 6,010 shares on 5/24/2024Ownership: 0.007%Burney Co.Sold 1,981 shares on 5/22/2024Ownership: 0.013%Comerica BankSold 7,686 shares on 5/17/2024Ownership: 0.098%View All Insider TransactionsView All Institutional Transactions FTRE Stock Analysis - Frequently Asked Questions Should I buy or sell Fortrea stock right now? 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fortrea in the last year. There are currently 1 sell rating, 4 hold ratings, 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" FTRE shares. View FTRE analyst ratings or view top-rated stocks. What is Fortrea's stock price target for 2024? 11 equities research analysts have issued twelve-month price targets for Fortrea's shares. Their FTRE share price targets range from $27.00 to $44.00. On average, they anticipate the company's share price to reach $32.78 in the next year. This suggests a possible upside of 29.1% from the stock's current price. View analysts price targets for FTRE or view top-rated stocks among Wall Street analysts. How have FTRE shares performed in 2024? Fortrea's stock was trading at $34.90 at the beginning of 2024. Since then, FTRE shares have decreased by 27.2% and is now trading at $25.39. View the best growth stocks for 2024 here. Are investors shorting Fortrea? Fortrea saw a drop in short interest in May. As of May 15th, there was short interest totaling 5,670,000 shares, a drop of 14.2% from the April 30th total of 6,610,000 shares. Based on an average trading volume of 1,110,000 shares, the days-to-cover ratio is presently 5.1 days. Approximately 6.4% of the company's stock are short sold. View Fortrea's Short Interest. When is Fortrea's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our FTRE earnings forecast. How were Fortrea's earnings last quarter? Fortrea Holdings Inc. (NASDAQ:FTRE) issued its quarterly earnings data on Monday, May, 13th. The company reported ($0.04) earnings per share for the quarter. The business had revenue of $662.10 million for the quarter, compared to the consensus estimate of $754.58 million. Fortrea had a positive trailing twelve-month return on equity of 4.76% and a negative net margin of 4.11%. Fortrea's revenue for the quarter was down 4.6% compared to the same quarter last year. What ETFs hold Fortrea's stock? ETFs with the largest weight of Fortrea (NASDAQ:FTRE) stock in their portfolio include LeaderShares Activist Leaders ETF (ACTV), Invesco S&P Spin-Off ETF (CSD), Invesco S&P SmallCap Health Care ETF (PSCH), iShares Factors US Value Style ETF (STLV), Vanguard S&P Small-Cap 600 Value ETF (VIOV), iShares S&P Small-Cap 600 Value ETF (IJS) and SPDR S&P 600 Small CapValue ETF (SLYV).Pacer BioThreat Strategy ETF (VIRS). What guidance has Fortrea issued on next quarter's earnings? Fortrea updated its FY 2024 earnings guidance on Monday, May, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.8 billion-$2.9 billion, compared to the consensus revenue estimate of $3.1 billion. Who are Fortrea's major shareholders? Fortrea's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.09%), Boston Partners (4.41%), Nordea Investment Management AB (1.10%), Iron Triangle Partners LP (0.89%), Magnetar Financial LLC (0.68%) and Penn Davis Mcfarland Inc. (0.64%). Insiders that own company stock include Peter M Neupert and Thomas Pike. View institutional ownership trends. How do I buy shares of Fortrea? Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FTRE) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeThe #1 Crypto That You Don’t Own… YetCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
